Knapp W, Prögel B, Knapp C
Dtsch Med Wochenschr. 1981 Aug 21;106(34):1054-60. doi: 10.1055/s-2008-1070452.
Using the Widal reaction, significant titres against Yersinia enterocolitica, O-group I and V, were found in 300 of 2843 patients (10.5%) with reactive arthritis or arthralgia, and in 38 (1.3%) against Y. pseudotuberculosis type I to V. Of 510 patients with erythema nodosum 86 (16.9%) and 30 (5.9%), respectively, had significant agglutinin titres against one or the other. The results confirm the aetiological significance of Y. pseudotuberculosis, type I to V, in reactive arthritis and erythema nodosum, as well as the essential saturation of patient sera especially with Salmonella of the B or D group in the demonstration of significant antibody titres against Y. pseudotuberculosis, type II and IV. Complement-fixation tests cannot be recommended for the diagnosis of enteric Yersiniosis and its complications. Only in 201 of 554 serum samples (36.3%) with significant agglutinin titres against Y. enterocolitica O-group I and V (0 : 3 and 0 : 9 after Winblad) did the results of the Widal reaction and the microcomplement-fixation reaction agree, titres apart.
采用肥达反应，在2843例反应性关节炎或关节痛患者中，有300例（10.5%）对小肠结肠炎耶尔森菌I群和V群有显著效价；在510例结节性红斑患者中，分别有86例（16.9%）和30例（5.9%）对其中一种或另一种有显著凝集素效价。结果证实了I型至V型假结核耶尔森菌在反应性关节炎和结节性红斑中的病因学意义，以及在显示针对II型和IV型假结核耶尔森菌的显著抗体效价时患者血清尤其是B群或D群沙门菌的基本饱和情况。补体结合试验不推荐用于诊断肠道耶尔森菌病及其并发症。在554份对小肠结肠炎耶尔森菌I群和V群有显著凝集素效价（温布拉德法检测后为0:3和0:9）的血清样本中，只有201份（36.3%）肥达反应和微量补体结合反应结果一致，效价情况除外。
